Medicinal Chemistry Research

, Volume 25, Issue 2, pp 356–368 | Cite as

Design, synthesis and neuraminidase inhibitory activity of N-(5-benzyl-4-(tert-butyl)thiazol-2-yl)benzamides

  • Zhilin Wu
  • Junmei Peng
  • Aixi HuEmail author
  • Jiao Ye
  • Guoxi Li
Original Research


A series of N-(5-benzyl-4-(tert-butyl)thiazol-2-yl)benzamides were synthesized and the structures were characterized by 1H NMR, MS and elemental analyses. The crystal structures of compounds F5 and F16 were determined by single-crystal X-ray diffraction. The neuraminidase inhibitory activities of compounds F1F32 were evaluated in vitro at the concentration of 40 μg/mL. The results indicated that compounds F8, F26 and F32 exhibited most potent inhibitory activity against NA. Molecular docking was performed by LeDock to further explain the structure–activity relationship of compound F26. The docking modeling showed that compound F26 was in good combination with oseltamivir binding sites of NA and could be a potential NA inhibitor agent.


Benzamide Thiazole NA inhibitory activity Crystal structure Molecular docking 



The authors would like to acknowledge and thank Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College for the NA inhibitory activities test.


  1. Abed Y, Nehmé B, Baz M, Boivin G (2008) Activity of the neuraminidase inhibitor A-315675 against oseltamivir–resistant influenza neuraminidases of N1 and N2 subtypes. Antiviral Res 77:163–166PubMedCrossRefGoogle Scholar
  2. Ah YC, Choi JK, Choi YK, Ki HM, Bae JH (2010) A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 385:12–19PubMedCrossRefGoogle Scholar
  3. Baz M, Abed Y, Boivin G (2007) Characterization of drug–resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res 74:159–162PubMedCrossRefGoogle Scholar
  4. Chang SH, Zhang JJ, Liao XY, Zhu XX, Wang DH, Zhu J, Feng T, Zhu BL, Gao GF, Wang J, Yang HM, Yu J, Wang J (2007) Influenza Virus Database (IVDB): an integrated information resource and analysis platform for influenza virus research. Nucleic Acids Res 35:376–380CrossRefGoogle Scholar
  5. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Mølbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu HJ, Vong S, Bresee J, Widdowson MA (2012) Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12:687–695PubMedCrossRefGoogle Scholar
  6. De Clercq E (2001) Antiviral drugs: current state of the art. J Clin Virol 22:73–89PubMedCrossRefGoogle Scholar
  7. Donaldson LJ, Rutter PD, Ellis BM, Greaves FEC, Mytton OT, Pebody RG, Yardley IE (2009) Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. Brit Med J 339:5213–5220CrossRefGoogle Scholar
  8. Gresser R, Hartmann H, Wrackmeyer M, Leo K, Riede M (2011) Synthesis of thiophene–substituted aza–BODIPYs and their optical and electrochemical properties. Tetrahedron 67:7148–7155CrossRefGoogle Scholar
  9. Hay AJ, Gregory V, Douglas AR, Lin YP (2001) The evolution of human influenza viruses. Phil Trans R Soc Lond B 356:1861–1870CrossRefGoogle Scholar
  10. Hilleman MR (2002) Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20:3068–3087PubMedCrossRefGoogle Scholar
  11. Hu AX, Cao G (2011) Hydrogen–bonded helices in 2–aminothiazole derivatives: generation of chiral crystals from small achiral molecules. Tetrahedron-Asymmetry 22:1332–1336CrossRefGoogle Scholar
  12. Hu J, Wang EH (2004) Studies on structure–activity relationship of influenza neuraminidase inhibitors. Progress in Pharmaceutical Sciences 28:204–208Google Scholar
  13. Ison MG (2012) Clinical use of approved influenza antivirals: therapy and prophylaxis. Influenza Other Respir Viruses 7(Suppl. 1):7–13Google Scholar
  14. Kessler U, Ranadheera C, Joubert M, Giethlen B, Garrido F (2010) Small molecule inhibitors of influenza A and B virus and respiratory syncytial virus replication. Pat WO2010128163A2Google Scholar
  15. Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand–protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778–2786PubMedCrossRefGoogle Scholar
  16. Li W, Xia L, Hu AX, Liu AL, Peng JM, Tan WQ (2013a) Design and synthesis of 4-Alkyl-2-amino-(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors. Arch Pharm Chem Life Sci 346:635–644CrossRefGoogle Scholar
  17. Li W, Hu AX, Liu AL, Peng JM, Xia L, Tan WQ (2013b) Synthesis and biological activities of 4-alkyl-6-aryl-1,3-thiazines. Chin J Org Chem 33:1478–1482CrossRefGoogle Scholar
  18. Liu AL, Cao HP, Du GH (2005) Drug screening for influenza neuraminidase inhibitors. Sci China Life Sci 48:1–5CrossRefGoogle Scholar
  19. Liu AL, Wang HD, Lee SM, Wang YT, Du GH (2008) Structure–activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti–viral activities. Bioorg Med Chem 16:7141–7147PubMedCrossRefGoogle Scholar
  20. Liu Y, Lei Z, Gong JZ, Fang H, Liu AL, Du GH, Xu WF (2011) Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors. J Enzyme Inhib Med Chem 26:506–513PubMedCrossRefGoogle Scholar
  21. Mitrasinovic PM (2009) On the structure–based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Biophys Chem 140:35–38PubMedCrossRefGoogle Scholar
  22. Moghadam MS, Maleki S, Darabpour E, Motamedi H, Nejad SMS (2010) Antibacterial activity of eight Iranian plant extracts against methicillin and cefixime resistant staphylococcus aureus strains. Asian Pac J Trop Med 3:262–265CrossRefGoogle Scholar
  23. Potter CW (2001) A history of influenza. J Appl Microbiol 91:572–579PubMedCrossRefGoogle Scholar
  24. Rossignal JF (2012) Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections. Pat WO2012158699A1Google Scholar
  25. Ryan DM, Ticehurst J, Dempsey MH (1995) GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetyl-neuraminic acid) is a potent inhibitor of influenza virus in ferrets. Antimicrob Agents Chemother 39:2583–2584PubMedPubMedCentralCrossRefGoogle Scholar
  26. Sheldrick GM (2004) SADABS. University of Göttingen, Germany, Program for the absorption correctionGoogle Scholar
  27. Shen F, Hu AX, Luo XF, Ye J, Ou XM (2012) Synthesis and Bioactivity of (E)-2-Benzylidenimino-4-(7-methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-5-yl) thiazole. Chin J Org Chem 32:388–392CrossRefGoogle Scholar
  28. Shen K, Peng JM, Li W, Yan XW, Hu AX (2014) Synthesis, crystal structure and antitumor activity of N-(4-tert-butyl-5-(4-chlorobenzyl)thiazol-2-yl)-2,6-difluorobenzamide. Chin J Struct Chem 33:855–858Google Scholar
  29. Stamboulian D, Bonvehi PE, Nacinovich FM, Cox N (2000) Influenza. Infect Dis Clin North Am 14:141–166PubMedCrossRefGoogle Scholar
  30. Stocks MJ, Harrison RP, Teague SJ (1995) Macrocyclic ring closures employing the intramolecular Heck Reaction. Tetrahedron Lett 36:6555–6558CrossRefGoogle Scholar
  31. Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM (2012) Oseltamivir–resistant pandemic (H1N1) (2009) virus infections, United States, 2010–11. Emerg Infect Dis 18:308–311PubMedPubMedCentralCrossRefGoogle Scholar
  32. Sun C, Zhang XD, Huang H, Zhou P (2006) Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3–α] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase. Bioorg Med Chem 14:8574–8581PubMedCrossRefGoogle Scholar
  33. Teoh D, Ayeni TA, Rubatt JM, Adams DJ, Grace L, Starr MD, Barry WT, Berchuck A, Murphy SK, Secord AA (2011) Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. Gynecol Oncol 121:187–192PubMedPubMedCentralCrossRefGoogle Scholar
  34. Vavricka CJ, Li Q, Wu Y, Qi JX, Wang MY, Liu Y, Gao F, Liu J, Feng EG, He JH, Wang JF, Liu H, Jiang HL, Gao GF (2011) Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathog 7:e1002249PubMedPubMedCentralCrossRefGoogle Scholar
  35. Wang T, Wade RC (2001) Comparative binding energy (COMBINE) analysis of influenza neuraminidase–inhibitor complexes. J Med Chem 44:961–971PubMedCrossRefGoogle Scholar
  36. Wang GT, Chen Y, Wang S, Gentles R, Sowin T, Kate W, Muchmore S, Giranda V, Stewart K, Sham H, Kempf D, Laver WG (2001) Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. J Med Chem 44:1192–1201PubMedCrossRefGoogle Scholar
  37. Wappes J (2013) China reports first human case of H10N8 avian flu.–perspective/ 2013/12/china–reports–first–human–case–h10n8–avian–flu
  38. WHO (2010) Pandemic (H1N1) 2009—update 111.
  39. Zhang AF, Okrasa L, Pakula T, Schlüter AD (2004) Homologous series of dendronized poly methacrylates with a methyleneoxycarbonyl spacer between the backbone and dendritic side chain: synthesis, characterization, and some bulk properties. J Am Chem Soc 126:6658–6666PubMedCrossRefGoogle Scholar
  40. Zhang J, Wang Q, Fang H, Xu WF, Liu AL, Du GH (2008) Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. Bioorgan Med Chem 16:3839–3847CrossRefGoogle Scholar
  41. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MHA, Huang SSH, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LLM, Webster RG, Webby RJ, Peiris JSM, Guan Y, Shu Y (2013) Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341:183–186PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Zhilin Wu
    • 1
  • Junmei Peng
    • 1
  • Aixi Hu
    • 1
    Email author
  • Jiao Ye
    • 1
  • Guoxi Li
    • 1
  1. 1.College of Chemistry and Chemical EngineeringHunan UniversityChangshaChina

Personalised recommendations